New publication: Spinal cord stimulation: A new perspective for SMA research by Rare Revolution Magazine.
We are delighted to invite you to read the latest Spinal cord stimulation: A new perspective for SMA research by Rare Revolution Magazine.
SMA Newsroom
SMA News Today latest article: "SMA Europe’s inaugural gathering to discuss medical emergencies"
We're excited to announce that SMA News Today has featured our 1st International Clinical Care Symposium on SMA, as part of their latest publication!
TreatmentsMar 28, 2025
Community update from Scholar Rock
Scholar Rock announced that the FDA has granted priority review for the Biologics License Application for apitegromab, an investigational muscle-targeted treatment developed to improve motor function for people living with SMA who are receiving an SMN-targeted treatment.
TreatmentsMar 21, 2025
Community update from Novartis: Phase III STEER and Phase IIIb STRENGTH studies
Novartis shared updates on the results from Phase III STEER and Phase IIIb STRENGTH studies, evaluating intrathecal onasemnogene abeparvovec (OAV101 IT) in people living with SMA aged two to <18 years.